| 62 | 4 | 10 |
| 下载次数 | 被引频次 | 阅读次数 |
目的:研究ⅠB~ⅡB期宫颈癌患者术前新辅助化疗对病灶内恶性生物学特征的影响。方法:选择2015年2月~2017年5月海军总医院诊断为ⅠB~ⅡB期宫颈癌并接受手术治疗的患者作为研究对象,随机分为术前接受新辅助化疗的辅助化疗组和进行常规术前准备的对照组。手术切除后,通过荧光定量PCR测定宫颈癌组织中抑癌基因、增殖基因、迁移和侵袭基因的mRNA表达量。结果:手术切除后,辅助化疗组宫颈癌组织中抑癌基因THBS2、PTEN、LAST1、eIF4E3的mRNA表达量显著高于常规手术组,增殖基因RUNX2、CyclinD1、ALEX1、ALDH1、ABCG2及迁移和侵袭基因CXCL12、CXCR4、MMP9、S100A6、N-cadherin的mRNA表达量显著低于常规手术组。差异均有统计学意义(P<0.05)。结论:ⅠB~ⅡB期宫颈癌患者术前新辅助化疗能够抑制病灶内癌细胞的增殖、迁移和侵袭。
Abstract：Objective:To study the effects of preoperative neoadjuvant chemotherapy on malignant biological characteristics in the lesions of patients withⅠB-ⅡB cervical cancer.Methods:Patients who were diagnosed withⅠB-ⅡB cervical cancer and underwent surgical treatment in Navy General Hospital of PLA between February 2015 and May 2017 were selected as the research subjects and randomly divided into the neoadjuvant chemotherapy group who underwent preoperative neoadjuvant chemotherapy and the control group who underwent routine preoperative preparation.After surgical resection,the mRNA expression of tumor suppressor genes,proliferation genes as well as migration and invasion genes in cervical cancer tissue were determined by fluorescence quantitative PCR.Results:After surgical resection,tumor suppressor genes THBS2,PTEN,LAST1 and eIF4 E3 mRNA expression in cervical cancer tissue of adjuvant chemotherapy group were significantly higher than those of control group whereas proliferation genes RUNX2,CyclinD1,ALEX1,ALDH1 and ABCG2 as well as migration and invasion genes CXCL12,CXCR4,MMP9,S100 A6 and N-cadherin mRNA expression were significantly lower than those of control group.Conclusion:Preoperative neoadjuvant chemotherapy can inhibit the proliferation,migration and invasion of cancer cells within the lesions of patients with ⅠB-ⅡB cervical cancer.
1 Jayant K,Sankaranarayanan R,Thorat RV,Muwonge R,Hingmire SJ,Panse NS,et al.Improved survival of cervical cancer patients in a screened population in Rural India[J].Asian Pac J Cancer Prev,2016,17(11):4837-4844.
2 Huang Z,Zheng Y,Wen W,Wu C,Bao P,Wang C,et al.Incidence and mortality of gynaecological cancers:Secular trends in urban Shanghai,China over 40 years[J].Eur J Cancer,2016,63:1-10.
3 Chen Z,Shi Y,Wang S,Lu Q.Meta-analysis showing that early response to neoadjuvant chemotherapy predicts better survival among cervical cancer patients[J].Oncotarget,2017,8(35):59609-59617.
4 de Azevedo CRAS,Thuler LCS,de Mello MJG,de Oliveira Lima JT,da Fonte ALF,Font?倞o DFS,et al.Phase II trial of neoadjuvant chemotherapy followed by chemoradiation in locally advanced cervical cancer[J].Gynecol Oncol,2017,146(3):560-5465.
5 Salihi R,Leunen K,Moerman P,Amant F,Neven P,Vergote I.Neoadjuvant weekly paclitaxel-carboplatin is effective in stage I-II cervical cancer[J].Int J Gynecol Cancer,2017,27(6):1256-1260.
6 Gadducci A,Barsotti C,Laliscia C,Cosio S,Fanucchi A,Tana R,et al.Dose-dense paclitaxel-and carboplatin-based neoadjuvant chemotherapy followed by surgery or concurrent chemo-radiotherapy in cervical cancer:apreliminary analysis[J].Anticancer Res,2017,37(3):1249-1255.
7 Wei WF,Zhou CF,Wu XG,He LN,Wu LF,Chen XJ,et al.MicroRNA-221-3p,a TWIST2target,promotes cervical cancer metastasis by directly targeting THBS2[J].Cell Death Dis,2017,8(12):3220.
8 Lee MS,Jeong MH,Lee HW,Han HJ,Ko A,Hewitt SM,et al.PI3K/AKT activation induces PTEN ubiquitination and destabilization accelerating tumourigenesis[J].Nat Commun,2015,17(6):7769.
9 Pang T,Wang S,Gao M,Kang H,Zhao Y,Yao Y,et al.HPV18E7induces the over-transcription of eIF4Egene in cervical cancer[J].Iran J Basic Med Sci,2015,18(7):684-690.
10 Asimomytis A,Karanikou M,Rodolakis A,Vaiopoulou A,Tsetsa P,Creatsas G,et al.mTOR downstream effectors,4 EBP1and eIF4E,are overexpressed and associated with HPV status in precancerous lesions and carcinomas of the uterine cervix[J].Oncol Lett,2016,12(5):3234-3240.
11 Chang WM,Lin YF,Su CY,Peng HY,Chang YC,Lai TC,et al.Dysregulation of RUNX2/Activin-A Axis upon miR-376c downregulation promotes lymph node metastasis in head and neck squamous cell carcinoma[J].Cancer Res,2016,76(24):7140-7150.
12 Sun SS,Zhang L,Yang J,Zhou X.Role of runt-related transcription factor 2in signal network of tumors as an inter-mediator[J].Cancer Lett,2015,361(1):1-7.
13 Park H,Lee M,Kim DW,Hong SY,Lee H.Glycogen synthase kinase 3βand cyclin D1expression in cervical carcinogenesis[J].Obstet Gynecol Sci,2016,59(6):470-478.
14 Zeng F,Liao K,Wu J,Gao Y,Li H,Fan J,et al.ALEX1may be a novel biomarker for human cervical squamous cell carcinoma[J].Int J Clin Exp Pathol,2015,8(8):9434-9439.
15 Xie Q,Liang J,Rao Q,Xie X,Li R,Liu Y,et al.Aldehyde dehydrogenase 1expression predicts chemoresistance and poor clinical outcomes in patients with locally advanced cervical cancer treated with neoadjuvant chemotherapy prior to radical hysterectomy[J].Ann Surg Oncol,2016,23(1):163-170.
16 Lv Y,Yang L,Wang F.Chemoradiation therapy reduces aldehyde dehydrogenase 1expression in cervical cancer but does not improve patient survival[J].Med Oncol,2015,32(5):155.
17 Sun R,Jiang B,Qi H,Zhang X,Yang J,Duan J,et al.SOX4contributes to the progression of cervical cancer and the resistance to the chemotherapeutic drug through ABCG2[J].Cell Death Dis,2015,19(6):e1990.
18 Dai Y,Tong R,Guo H,Yu T,Wang C.Association of CXCR4,CCR7,VEGF-C and VEGF-D expression with lymph node metastasis in patients with cervical cancer[J].Eur J Obstet Gynecol Reprod Biol,2017,214:178-183.
19 Wang C,Cheng H,Li Y.Role of SDF-1and CXCR4in the proliferation,migration and invasion of cervical cancer[J].Pak J Pharm Sci,2016,29(6Spec):2151-2154.
20 Sapkota D,Bruland O,Parajuli H,Osman TA,Teh MT,Johannessen AC,et al.S100A16 promotes differentiation and contributes to a less aggressive tumor phenotype in oral squamous cell carcinoma[J].BMC Cancer,2015,9(15):631.
21 李爱芳,谷月,李雪茹,等.S100A6促宫颈癌细胞增殖、迁移及其可能机制研究[J].中国生物工程杂志,2017,37(2):8-14.
22 Lin J,Liu X,Ding D.Evidence for epithelial-mesenchymal transition in cancer stem-like cells derived from carcinoma cell lines of the cervix uteri[J].Int J Clin Exp Pathol,2015,8(1):847-855.
基本信息:
DOI：10.13210/j.cnki.jhmu.20180208.004
中图分类号:R737.33
引用信息:
[1]翟妍,杨超,马军朋,等.ⅠB～ ⅡB期宫颈癌患者术前新辅助化疗对病灶内恶性生物学特征的影响[J].海南医学院学报,2018,24(04):534-536+540.DOI:10.13210/j.cnki.jhmu.20180208.004.
基金信息:
北京市民健康培育(Z151100003915112)~~
2018-02-08
2018-02-08
2018-02-08